Search Within

Gregory J Riely

  1. "Kathryn Arbour"
Formats
  1. Journal Article (25)
  2. Meeting Abstract (16)
  3. Review (1)
Groups
  1. Department of Medicine (42)
  2. Hematology-Oncology Fellows (42)
  3. Solid Tumor Oncology Division (42)
  4. Thoracic Oncology (42)
  5. Weinberg Fellows (42)
  6. GSK Faculty (28)

More Groups

People
  1. Kathryn Arbour (42)
  2. Mark Kris (21)
  3. Matthew Hellmann (20)
  4. Charles Rudin (17)
  5. Marc Ladanyi (17)
  6. Piro Lito (16)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (4)
  4. 2022 (3)
  5. 2021 (7)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (15)
  2. Clinical Cancer Research (5)
  3. Annals of Oncology (4)
  4. Cancer Research (3)
  5. Cancer (2)
  6. JCO Precision Oncology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (17)
  2. American Association for Cancer Research (9)
  3. Oxford University Press (5)
  4. Elsevier Inc. (2)
  5. Nature Publishing Group (2)
  6. Wiley Blackwell (2)

More Publishers

Results (42)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of MTAP deletion on immunotherapy outcomes in patients with mesothelioma
    Meeting Abstract

    Ross, J.; Ortiz, E.; Barraza, G.; Mayoral, M.; Ginsberg, M. S.; Luongo, A.; Arfe, A.; Zauderer, M. G.; Adusumilli, P. S.; Eckert, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A phase 2 study of amivantamab plus lazertinib in patients with EGFR-mutant lung cancer and active central nervous system disease
    Meeting Abstract

    Yu, H. A.; Chen, M. F.; Hui, A. B.; Choudhury, N. J.; Lee, J. J. K.; Zheng, J.; Ahn, L. S. H.; Pupo, A.; Nesselbush, M.; Jabara, I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Genomic landscape of MTAP deletions and association with EGFR alterations in NSCLC
    Meeting Abstract

    Thummalapalli, R.; Muldoon, D.; Febres-Aldana, C. A.; Falcon, C. J.; Pupo, A.; Bandlamudi, C.; Berger, M. F.; Yu, H. A.; Riely, G. J.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Clinical and genomic features of response and toxicity to sotorasib in a real-world cohort of patients with advanced KRAS G12C-mutant non-small cell lung cancer
    Journal Article

    Thummalapalli, R.; Bernstein, E.; Herzberg, B.; Li, B. T.; Iqbal, A.; Preeshagul, I.; Santini, F. C.; Eng, J.; Ladanyi, M.; Yang, S. R.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Outcomes of combination platinum-doublet chemotherapy and anti-PD(L)-1 blockade in KRAS(G12C) mutant non-small cell lung cancer
    Journal Article

    Elkrief, A.; Riccuiti, B.; Alessi, J. V.; Fei, T.; Kalvin, H. L.; Egger, J. V.; Rizvi, H.; Thummalapalli, R.; Lamberti, G.; Plodkowski, A.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • The GENIE BPC NSCLC cohort: A real-world repository integrating standardized clinical and genomic data for 1,846 patients with non-small cell lung cancer
    Journal Article

    Choudhury, N. J.; Lavery, J. A.; Brown, S.; de Bruijn, I.; Jee, J.; Tran, T. N.; Rizvi, H.; Arbour, K. C.; Whiting, K.; Shen, R.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Clinical and genomic predictors of response and toxicity to sotorasib in a real-world cohort of patients with advanced KRAS G12C-mutant non-small cell lung cancer
    Meeting Abstract

    Arbour, K. C.; Thummalapalli, R.; Bernstein, E.; Herzberg, B.; Li, B. T.; Iqbal, A.; Santini, F. C.; Eng, J.; Ladanyi, M.; Yang, S. R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Genomic landscapes and hallmarks of mutant RAS in human cancers
    Journal Article

    Scharpf, R. B.; Balan, A.; Ricciuti, B.; Fiksel, J.; Cherry, C.; Wang, C.; Lenoue-Newton, M. L.; Rizvi, H. A.; White, J. R.; Baras, A. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Phase 1 clinical trial of trametinib and ponatinib in patients with NSCLC harboring KRAS mutations
    Journal Article

    Arbour, K. C.; Manchado, E.; Bott, M. J.; Ahn, L.; Tobi, Y.; Ni, A. A.; Yu, H. A.; Shannon, A.; Ladanyi, M.; Perron, V.; more...
    JTO Clinical and Research Reports (2022)

    Fulltext@MSK | Save